Perhaps in the future study, chemotherapy combined with anti-CTLA-4 and anti-PD-1 therapies might be one of the therapeutic modalities for chemotherapy-naive SCLC patients. This evidence concerns the gene PDCD1 and small cell lung carcinoma.